A collaboration between virologists and neuroscientists at Cambridge ̽»¨Ö±²¥ has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson’s and other neurodegenerative diseases.
A ̽»¨Ö±²¥ of Cambridge study, which set out to investigate DNA methylation in the human heart and the "missing link" between our lifestyle and our health, has now mapped the link in detail across the entire human genome.
Allergy experts at the ̽»¨Ö±²¥ of Cambridge have convincing evidence that a new treatment for peanut allergies is effective, following a three-year trial.
Scientists have identified a diabetes drug which halves the mortality rate of a deadly infectious disease found throughout Southeast Asia and Northern Australia.
Work in resource-restricted healthcare settings in south-east Asia is defining the transmission of hospital ‘superbugs’ using low-tech diagnostics and high-tech tools.
A new method for identifying which bones have a high risk of fracture, and for monitoring the effectiveness of new bone-strengthening drugs and techniques, has been developed by scientists at the ̽»¨Ö±²¥ of Cambridge.
̽»¨Ö±²¥expertise of Cambridge's new Professor of Clinical Microbiology, Sharon Peacock, is helping to drive a programme of research that will track and block routes of transmission for superbugs.
Scientists have found what they believe is the missing link between heart failure, our genes and our environment. ̽»¨Ö±²¥study could open up completely new ways of managing and treating heart disease.
Scientists from Cambridge ̽»¨Ö±²¥ have discovered four rare mutations of a gene associated with type 1 diabetes (T1D) that reduce the risk of developing the disease. Their findings, published today in the journal Science, suggest a link between T1D and the enterovirus (a common virus that enters via the gastrointestinal tract but is often non-symptomatic).
© 2025 ̽»¨Ö±²¥ of Cambridge